Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 192

1.

Immunohistochemically determined estrogen receptor phenotype remains stable in recurrent and metastatic breast cancer.

Gomez-Fernandez C, Daneshbod Y, Nassiri M, Milikowski C, Alvarez C, Nadji M.

Am J Clin Pathol. 2008 Dec;130(6):879-82. doi: 10.1309/AJCPD1AO3YSYQYNW.

PMID:
19019763
[PubMed - indexed for MEDLINE]
Free Article
2.

Immunohistochemical detection of estrogen receptors in paraffin sections from primary and metastatic breast cancer.

Brunn Rasmussen B, Kamby C.

Pathol Res Pract. 1989 Dec;185(6):856-9.

PMID:
2616369
[PubMed - indexed for MEDLINE]
3.

Estrogen receptor mutations and changes in estrogen receptor and progesterone receptor protein expression in metastatic or recurrent breast cancer.

Umekita Y, Sagara Y, Yoshida H.

Jpn J Cancer Res. 1998 Jan;89(1):27-32.

PMID:
9510472
[PubMed - indexed for MEDLINE]
4.

Long-term pattern of disease recurrence among patients with early-stage breast cancer according to estrogen receptor status and use of adjuvant tamoxifen.

Khoshnoud MR, Fornander T, Johansson H, Rutqvist LE.

Breast Cancer Res Treat. 2008 Jan;107(1):71-8. Epub 2007 Feb 15.

PMID:
18043896
[PubMed - indexed for MEDLINE]
5.

Estrogen receptor expression profile of disseminated epithelial tumor cells in bone marrow of breast cancer patients.

Ditsch N, Mayer B, Rolle M, Untch M, Schildberg FW, Funke I.

Recent Results Cancer Res. 2003;162:141-7.

PMID:
12790328
[PubMed - indexed for MEDLINE]
6.

Variation in receptor status between primary and metastatic breast cancer.

Holdaway IM, Bowditch JV.

Cancer. 1983 Aug 1;52(3):479-85.

PMID:
6861087
[PubMed - indexed for MEDLINE]
7.

Variation of ER status between primary and metastatic breast cancer and relationship to p53 expression*.

Zheng WQ, Lu J, Zheng JM, Hu FX, Ni CR.

Steroids. 2001 Dec;66(12):905-10.

PMID:
11711119
[PubMed - indexed for MEDLINE]
8.

Correlation between immunohistochemical and biochemical estrogen receptors in the prognosis of patients with breast cancer.

Chariyalertsak S, Thisuphakorn P, Ruangvejvorachai P.

Asian Pac J Allergy Immunol. 1999 Jun;17(2):107-12.

PMID:
10466546
[PubMed - indexed for MEDLINE]
Free Article
9.

Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival.

Cheang MC, Treaba DO, Speers CH, Olivotto IA, Bajdik CD, Chia SK, Goldstein LC, Gelmon KA, Huntsman D, Gilks CB, Nielsen TO, Gown AM.

J Clin Oncol. 2006 Dec 20;24(36):5637-44. Epub 2006 Nov 20.

PMID:
17116944
[PubMed - indexed for MEDLINE]
Free Article
10.

[Biological significance of estrogen receptor status in axillary lymph node metastases of invasive ductal breast cancers].

Horst HA, Horny HP, Gent HJ, Sellschopp C, Hedderich J.

Klin Wochenschr. 1988 Dec 1;66(23):1160-6. German.

PMID:
2850408
[PubMed - indexed for MEDLINE]
11.

Influence of estrogen receptor status on response to combination chemotherapy for recurrent breast cancer.

Mortimer J, Reimer R, Greenstreet R, Groppe C, Bukowski R.

Cancer Treat Rep. 1981 Sep-Oct;65(9-10):763-6.

PMID:
7273011
[PubMed - indexed for MEDLINE]
12.
13.

Comparative study of the immunohistochemical detection of hormone receptor status and HER-2 expression in primary and paired recurrent/metastatic lesions of patients with breast cancer.

Sari E, Guler G, Hayran M, Gullu I, Altundag K, Ozisik Y.

Med Oncol. 2011 Mar;28(1):57-63. doi: 10.1007/s12032-010-9418-2. Epub 2010 Jan 23.

PMID:
20099049
[PubMed - indexed for MEDLINE]
14.

Correlation of estrophilin content of primary mammary cancer to eventual endocrine treatment.

Block GE, Ellis RS, DeSombre E, Jensen E.

Ann Surg. 1978 Sep;188(3):372-6.

PMID:
686899
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Hormone receptor and c-ERBB2 status in distant metastatic and locally recurrent breast cancer. Pathologic correlations and clinical significance.

Idirisinghe PK, Thike AA, Cheok PY, Tse GM, Lui PC, Fook-Chong S, Wong NS, Tan PH.

Am J Clin Pathol. 2010 Mar;133(3):416-29. doi: 10.1309/AJCPJ57FLLJRXKPV.

PMID:
20154280
[PubMed - indexed for MEDLINE]
Free Article
16.

Automated immunohistochemical assay for estrogen receptor status in breast cancer using monoclonal antibody CC4-5 on the Ventana ES.

Nichols GE, Frierson HF Jr, Boyd JC, Hanigan MH.

Am J Clin Pathol. 1996 Sep;106(3):332-8.

PMID:
8816590
[PubMed - indexed for MEDLINE]
17.

Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management.

Guarneri V, Giovannelli S, Ficarra G, Bettelli S, Maiorana A, Piacentini F, Barbieri E, Dieci MV, D'Amico R, Jovic G, Conte P.

Oncologist. 2008 Aug;13(8):838-44. doi: 10.1634/theoncologist.2008-0048. Epub 2008 Jul 23.

PMID:
18650259
[PubMed - indexed for MEDLINE]
Free Article
18.

Comparison of immunohistological parameters in primary breast cancers and corresponding locoregional recurrences.

Rom J, Aulmann S, Schneeweiss A, Sohn C, Sinn HP.

Pathol Res Pract. 2006;202(3):125-30. Epub 2006 Feb 3.

PMID:
16458445
[PubMed - indexed for MEDLINE]
19.

[Changing behavior of estrogen and progesterone receptors with metastasis or recurrence of breast cancer].

Morimoto K, Koh M, Yamamoto A, Tamura K, Yamamoto K, Yamamoto K, Suehiro S.

Gan To Kagaku Ryoho. 2006 Jul;33(7):925-9. Japanese.

PMID:
16835481
[PubMed - indexed for MEDLINE]
20.

Tissue confirmation of disease recurrence in breast cancer patients: pooled analysis of multi-centre, multi-disciplinary prospective studies.

Amir E, Clemons M, Purdie CA, Miller N, Quinlan P, Geddie W, Coleman RE, Freedman OC, Jordan LB, Thompson AM.

Cancer Treat Rev. 2012 Oct;38(6):708-14. doi: 10.1016/j.ctrv.2011.11.006. Epub 2011 Dec 16.

PMID:
22178456
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk